Company intelligence / Profile preview

Zhongjing Wanxi Pharmaceutical

Nanyang（Xixia county）, Henan, 中国（China）henanwanxi.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Zhongjing Wanxi Pharmaceutical has a large commercial portfolio of traditional Chinese medicines and health products. Its best-known product—Liuwei Dihuang pills ("Pills of Six Ingredients with Rehmannia")—is a market leader in China with annual sales exceeding $24 million. The company also has at least one product ("Yinao Jieyu Granules") in Phase 2 clinical trials for major depressive disorder[3][5][2].

Therapeutic areas: PsychiatryCardiovascularWomen's Health
Modalities: Small moleculeHerbal medicineTraditional Chinese medicine
Industry: Biotech

Drug pipeline

3 assets

Yi'nao Jieyu Granules

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Zhongjing Wanxi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongjing Wanxi Pharmaceutical.

Explore the full profile